Analyst Josh Schimmer works at EVERCORE and is focused on the Healthcare sector with 416 price targets and ratings documented since 2013 spanning on 11 stocks. Previously, Josh Schimmer worked at PIPER SANDLER. Analyst's average stock valuation to be materialised ratio is 58.45% with an average time for price targets to be met of 337.82 days.
Most recent stock forecast was given on MYOV, Myovant Sciences Ltd at 26-Oct-2022.
Josh Schimmer best performing recommendations are on SPRO.
The best stock recommendation documented was for SPRO at 5/4/2022. The price target of $2 was fulfilled within 2 days with a profit of $0.25 (14.29%) receiving and performance score of 71.43.
Average potential price target upside